At the end of last week, U.S. Rep. Donna Shalala, D-Fla., announced that the federal government was sending a grant to a biopharmaceutical company located in South Florida.
Shalala showcased the U.S. Department of Health and Human Services (HHS) is sending $225,000 grant to Everglades Biopharma, LLC. During President Bill Clinton’s administration, Shalala served as HHS secretary.
On Friday, Shalala weighed in on Everglades Biopharma being awarded the grant.
“With the Centers for Disease Control estimating that the number of Americans with vision loss will double by 2050, the research and development that Everglades Biopharma is doing is now more important than ever. I am pleased that the National Eye Institute has decided to award this grant to Everglades Biopharma so that it can continue its innovative research,” Shalala said.
According to Shalala’s office, the funds will go to “research in gene therapy to combat vision loss.”
HHS sent $225,000 to Everglades Biopharma back in 2017 to work with the University of Miami Medical School to develop therapy for diabetic retinopathy.
Reach Kevin Derby at firstname.lastname@example.org.